SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. to the U.S. Securities and Exchange Commission. The reporting period covers holdings as of September 30, 2023. This document discloses Alphabet's equity securities held with sole, shared, or dispositive voting authority, rather than reporting Alphabet's own operational financial performance.
Key Financial Metrics and Portfolio Composition
The filing details Alphabet's investment portfolio, which consists primarily of common stock and American Depositary Receipts (ADRs). The portfolio is heavily weighted toward the biotechnology, healthcare, and technology sectors.
- Total Disclosed Positions: The table lists 48 distinct line items across various issuers.
- Top Holdings by Value (Selected):
- Arm Holdings PLC: $104,941,160 (1,960,784 shares)
- UiPath Inc. (Class A): $233,766,111 (13,662,543 shares)
- Planet Labs PBC: $83,050,867 (31,942,641 shares)
- Prime Medicine Inc: $113,168,230 (11,862,498 shares)
- Verve Therapeutics Inc: $137,486,164 (10,368,489 shares)
- CrowdStrike Holdings Inc: $214,862,861 (1,283,683 shares)
- Voting Authority: Most positions are reported with "Sole" voting authority, though some entries indicate "Shared" or "None" authority.
Material Changes and Comparisons
The provided text contains only the snapshot of holdings for the period ending September 30, 2023. It does not provide comparative data from the prior quarter (June 30, 2023) or year-over-year figures. Consequently, material changes in position size, new acquisitions, or divestitures cannot be determined from this document alone.
Guidance, Outlook, and Risks
As a statutory disclosure of equity holdings, this Form 13F does not contain management commentary, financial guidance, risk factors, or outlook statements regarding Alphabet's own business operations. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of Alphabet's disclosed equity portfolio by summing the "Value" column, noting that this represents only a subset of potential holdings (e.g., derivatives or non-reportable positions may be excluded).
- Compare these holdings against Alphabet's prior 13F filings to identify significant shifts in sector allocation (e.g., increased exposure to biotech vs. software).
- Confirm the voting authority status for large positions to understand Alphabet's potential influence on corporate governance of investee companies.
- Note that this filing reflects Alphabet's investment arm activities and does not reflect the company's core revenue-generating segments (Search, Cloud, YouTube).